RAINBOW · Healthcare
The board meets on 31 Oct 2026 to approve the results. This page fills in when the numbers are filed.
| Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹333 cr | ₹336 cr | ₹341 cr | ₹330 cr | ₹417 cr | ₹398 cr | ₹370 cr | ₹353 cr | ₹445 cr | ₹445 cr | ₹460 cr | ₹470 cr |
| YoY | — | — | — | +15% | +25% | +18% | +9% | +7% | +7% | +12% | +24% | +33% |
| EBITDA margin | 35.4% | 35.1% | 31.1% | 28.5% | 35.3% | 33.7% | 31.1% | 29.5% | 33.5% | 33.0% | 31.5% | 28.7% |
| Other income, % of PBT | 9% | 11% | 19% | 23% | 10% | 14% | 19% | 28% | 8% | 11% | 5% | 15% |
| Exceptional items | — | — | — | — | — | — | — | — | — | — | — | — |
| Tax rate | 26% | 26% | 26% | 26% | 25% | 27% | 27% | 25% | 26% | 24% | 10% | 26% |
| Net profit | ₹63.0 cr | ₹63.0 cr | ₹51.0 cr | ₹40.0 cr | ₹79.0 cr | ₹69.0 cr | ₹57.0 cr | ₹54.0 cr | ₹76.0 cr | ₹74.0 cr | ₹78.0 cr | ₹63.0 cr |
| YoY | — | — | — | −5% | +25% | +10% | +12% | +35% | −4% | +7% | +37% | +17% |
| Core profit YoY | — | — | — | −15% | +22% | +7% | +11% | +24% | 0% | +7% | +34% | +39% |
| EPS | ₹6.20 | ₹6.12 | ₹5.02 | ₹3.89 | ₹7.77 | ₹6.76 | ₹5.55 | ₹5.27 | ₹7.41 | ₹7.14 | ₹7.59 | ₹5.96 |
| Flags | · | · | · | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 1 | ✓ |
Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.
Numbers as filed with the exchanges, read by rules. Every flag is a question with its source, not an accusation. FinMinutes is a financial data and analytics platform; nothing here is a recommendation to buy, sell or hold any security. How each check works.